Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04586400 · ClinicalTrials.gov registry record

Chromosome 9 P Minus Syndrome

A clinical trial of Chromosome 9P Deletion Syndrome and 9p Minus Syndrome, sponsored by Washington University School of Medicine.

Recruiting
Registry status
200
Enrollment target
1
Study location

NCT04586400 is a study of Chromosome 9P Deletion Syndrome and 9p Minus Syndrome that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04586400, a study of Chromosome 9P Deletion Syndrome and 9p Minus Syndrome, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
200 participants
Enrollment target
1
Study location

Study Summary

Patients with deletion of chromosome 9 P are rare (\~200 in the medical literature) and have a diverse set of phenotypic characteristics. We propose using state of the art genome sequencing methods to define the location and size of the deleted portion of chromosome 9 P as well as the genetic background in affected patients (whole genome sequencing) and correlate the genes in the deleted portion of chromosome 9 P with specific phenotypic characteristics of each patient. Enrolled participants will be asked to complete a detailed questionnaire, complete a medical release form, and provide a biospecimen sample.

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2017-06-27
Est. Completion 2026-06

What the Registry Record Tells You About NCT04586400

The ClinicalTrials.gov registry entry for NCT04586400 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Chromosome 9P Deletion Syndrome appearing as the primary indexed condition, and to 0 interventions.

NCT04586400 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT04586400 about?

NCT04586400 is a clinical study titled "Chromosome 9 P Minus Syndrome". Patients with deletion of chromosome 9 P are rare (\~200 in the medical literature) and have a diverse set of phenotypic characteristics. We propose using state of the art genome sequencing methods to define the location and size of the deleted portion of chromosome 9 P as well as the genetic backgr...

What is the current status of trial NCT04586400?

This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2017-06-27. Estimated completion is 2026-06.

What conditions does trial NCT04586400 study?

This clinical trial studies the following conditions: Chromosome 9P Deletion Syndrome, 9p Minus Syndrome, Alfi Syndrome, 9P Monosomy, 9P Partial Monosomy Syndrome.

Who is sponsoring clinical trial NCT04586400?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04586400 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.